The Emmes Company, Llc

Rank #763 of 1,000 by FY2025 federal contract value · Headquarters: ROCKVILLE, MD

FY2025 contract value

$72,702,878

Oct 1, 2024 – Sep 30, 2025

FY2024 contract value

$100,091,398

FY2023 contract value

$97,622,223

Top agency (FY2025)

Department of Health and Human Services

$72,702,878

Company profile

Legal name (as listed): THE EMMES COMPANY, LLC
UEI: NBQCBJ6FXBU4
DUNS: 096360284
Headquarters: ROCKVILLE, MD
Business types: Category BusinessCorporate Entity Not Tax ExemptLimited Liability CorporationOther Than Small BusinessSpecial DesignationsUS Owned Business

Contract value trend, FY2023 – FY2025

Fiscal year	Contract value	Change vs prior year
FY2023	$97,622,223	—
FY2024	$100,091,398	+2.5%
FY2025	$72,702,878	-27.4%

FY2025 breakdowns

Top 10 in each category by FY2025 contract value.

Top awarding agencies

Department of Health and Human ServicesHHS

$72,702,878

Top places of performance (states)

MarylandMD	$72,703,222
PennsylvaniaPA	-$344

Top industries (NAICS)

Research and Development in Nanotechnology541713	$26,737,744
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)541715	$17,930,440
Administrative Management and General Management Consulting Services541611	$17,923,191
Research and Development in Biotechnology541711	$5,961,918
Custom Computer Programming Services541511	$1,997,920
Research and Development in Biotechnology (except Nanobiotechnology)541714	$1,201,038
Other Scientific and Technical Consulting Services541690	$932,116
Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)541712	$18,511

Top product & service codes (PSC)

SUPPORT- MANAGEMENT: DATA COLLECTIONR702	$26,703,606
HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCHAN11	$11,662,692
HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENTAN13	$9,200,000
SUPPORT- ADMINISTRATIVE: OTHERR699	$8,226,944
SUPPORT- PROFESSIONAL: OTHERR499	$7,870,176
HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCHAN12	$7,422,255
SUPPORT- MANAGEMENT: CONTRACT/PROCUREMENT/ACQUISITION SUPPORTR707	$1,997,920
R&D- OTHER RESEARCH AND DEVELOPMENT (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT)AZ12	-$25,072
R&D- OTHER RESEARCH AND DEVELOPMENT (OPERATIONAL SYSTEMS DEVELOPMENT)AZ15	-$355,642

Contract awards

Up to 20 awards with activity in FY2025, newest start date first. Amounts are individual award obligations, not company totals.

Award ID	Amount	Awarding agency	Description	Start date	NAICS	PSC	Place
CONT_AWD_75N95025F00001_7529_75N95024D00037_7529	$4,656,081	Department of Health and Human Services	TO4. CLINICAL COORDINATING CENTER FOR NIDA'S CLINICAL TRIALS NETWORK. CONTRACT TYPE: IDIQ TASK ORDER. POP: 8/15/24 - 8/14/29	Jul 16, 2025	—	—	MD
CONT_AWD_75N95025F00002_7529_75N95024D00037_7529	$2,501,452	Department of Health and Human Services	TO5. CLINICAL COORDINATING CENTER FOR NIDA'S CLINICAL TRIALS NETWORK. CONTRACT TYPE: IDIQ TASK ORDER. POP: 8/15/24 - 8/14/29	Jul 16, 2025	—	—	MD
CONT_AWD_75N95025F00002_7529_75N95022D00017_7529	$1,747,575	Department of Health and Human Services	DATA AND STATISTICAL ANALYSIS FOR GLP-1 AS AN ADJUNCT TO BUPRENORPHINE. MAY 21, 2025 - FEBRUARY 29, 2028. N01DA-22-2253. TASK ORDER NO. 75N95025F00002 (TO26).	May 21, 2025	—	—	MD
CONT_AWD_75N95025F00001_7529_75N95022D00017_7529	$2,349,295	Department of Health and Human Services	DSC MANAGEMENT AND SUPPORT. MARCH 1, 2025 TO FEBRUARY 28, 2026. N01DA-22-2253. TASK ORDER NO. 75N95025F00001 (TO25).	Mar 1, 2025	—	—	MD
CONT_AWD_75N95024F00003_7529_75N95024D00037_7529	$3,944,274	Department of Health and Human Services	CTN'S CLINICAL COORDINATING CENTER CONTRACT. CTN STUDY, OPTIMIZING RETENTION, DURATION AND DISCONTINUATION STRATEGIES FOR OPIOID USE DISORDER PHARMACOTHERAPY (CTN-0100). POP: 8/15/24 - 4/2/28	Aug 15, 2024	—	—	MD
CONT_AWD_75N95024F00007_7529_75N95022D00017_7529	$1,860,579	Department of Health and Human Services	OPTIMIZING RETENTION, DURATION AND DISCONTINUATION STRATEGIES FOR OPIOID USE DISORDER PHARMACOTHERAPY (CTN-0100). AUGUST 15, 2024 TO MARCH 31, 2028. N01DA-22-2253. TASK ORDER NO. 75N95024F00007 (TO23).	Aug 15, 2024	—	—	MD
CONT_AWD_75N95024F00008_7529_75N95022D00017_7529	$771,451	Department of Health and Human Services	RURAL EXPANSION OF MEDICATION TREATMENT FOR OPIOID USE DISORDER (CTN-0102). AUGUST 1, 2024 TO MARCH 31, 2026. N01DA-22-2253. TASK ORDER NO. 75N95024F00008 (TO24).	Aug 1, 2024	—	—	MD
CONT_AWD_75N95024F00001_7529_75N95022D00017_7529	$374,923	Department of Health and Human Services	PHARMACIST-INTEGRATED MODEL OF MEDICATION TREATMENT FOR OPIOID USE DISORDER. 12/01/2023 - 03/31/2025. N01DA-22-2253. TASK ORDER NO. 75N95024F00001 (TO17).	Dec 1, 2023	—	—	MD
CONT_AWD_75N95023F00005_7529_75N95022D00017_7529	$1,249,376	Department of Health and Human Services	STANDARD AND HIGH DOSE ED BUPRENORPHINE INDUCTION. 09/15/2023 - 05/31/2026. N01DA-22-2253. TASK ORDER 75N95023F00005 (TO9).	Sep 15, 2023	—	—	MD
CONT_AWD_75N95023F00011_7529_75N95022D00017_7529	$799,919	Department of Health and Human Services	CRAFT. SEPTEMBER 15, 2023 - MARCH 31, 2025. N01DA-22-2253. TASK ORDER NO. 75N95023F00011 (TO15).	Sep 15, 2023	—	—	MD
CONT_AWD_75N95023F00012_7529_75N95022D00017_7529	$754,669	Department of Health and Human Services	SECONDARY ANALYSIS. SEPTEMBER 15, 2023 - SEPTEMBER 14, 2026. N01DA-22-2253. TASK ORDER NO. 75N95023F00012 (TO16)	Sep 15, 2023	—	—	MD
CONT_AWD_75N98022F00001_7529_75N98022D00012_7529	$4,027,835	Department of Health and Human Services	EMMES CORP:1108738 [22-001337]	Mar 28, 2022	—	—	MD
CONT_AWD_75N98022C00001_7529_-NONE-_-NONE-	$30,142,554	Department of Health and Human Services	EO14042 DEVELOPMENT, STATISTICAL DESIGN, MONITORING AND COORDINATION OF VISION CLINICAL TRIALS AND EPIDEMIOLOGY RESEARCH	Nov 1, 2021	—	—	MD
CONT_AWD_HHSN271201700064C_7529_-NONE-_-NONE-	$6,970,620	Department of Health and Human Services	IGF::OT::IGF OTHER FUNCTION NINDS CENTER FOR CLINICAL RESEARCH RESOURCES	Sep 19, 2017	—	—	MD
CONT_AWD_HHSN275201700002C_7529_-NONE-_-NONE-	$66,032,644	Department of Health and Human Services	IGF::OT::IGF DATA COORDINATING CENTER FOR THE BEST PHARMACEUTICALS FOR CHILDREN ACT	Jul 28, 2017	—	—	MD
CONT_AWD_HHSN263201700001C_7529_-NONE-_-NONE-	$35,391,880	Department of Health and Human Services	IGF::OT::IGF EMMES NEIS-V	Oct 26, 2016	—	—	MD
CONT_AWD_HHSN26800003_7529_HHSN268201400002I_7529	$13,756,583	Department of Health and Human Services	IGF::OT::IGF THE NATIONAL MYELODYSPLASTIC SYNDROMES (MDS) NATURAL HISTORY STUDY, DATA COORDINATING CENTER (DCC), TASK ORDER 03, SEPTEMBER 1, 2016-FEBRUARY 28, 2018	Aug 30, 2016	—	—	MD
CONT_AWD_HHSN268201600020C_7529_-NONE-_-NONE-	$4,756,253	Department of Health and Human Services	IGF::OT::IGF PRODUCTION ASSISTANCE FOR CELLULAR THERAPIES (PACT) - COORDINATING CENTER (CC)	Jul 1, 2016	—	—	MD
CONT_AWD_HHSN27200008_7529_HHSN272201000049I_7529	$125,282	Department of Health and Human Services	IGF::OT::IGF	Nov 18, 2015	—	—	MD
CONT_AWD_HHSN272201500002C_7529_-NONE-_-NONE-	$100,150,458	Department of Health and Human Services	IGF::OT::IGF - STATISTICAL AND DATA COORDINATING CENTER FOR CLINICAL RESEARCH IN INFECTIOUS DISEASES(SDCC)	Feb 27, 2015	—	—	MD

CONT_AWD_75N95025F00001_7529_75N95024D00037_7529

$4,656,081

Awarding agency: Department of Health and Human Services

Description: TO4. CLINICAL COORDINATING CENTER FOR NIDA'S CLINICAL TRIALS NETWORK. CONTRACT TYPE: IDIQ TASK ORDER. POP: 8/15/24 - 8/14/29

Start date: Jul 16, 2025

NAICS: —

PSC: —

Place: MD

CONT_AWD_75N95025F00002_7529_75N95024D00037_7529

$2,501,452

Awarding agency: Department of Health and Human Services

Description: TO5. CLINICAL COORDINATING CENTER FOR NIDA'S CLINICAL TRIALS NETWORK. CONTRACT TYPE: IDIQ TASK ORDER. POP: 8/15/24 - 8/14/29

Start date: Jul 16, 2025

NAICS: —

PSC: —

Place: MD

CONT_AWD_75N95025F00002_7529_75N95022D00017_7529

$1,747,575

Awarding agency: Department of Health and Human Services

Description: DATA AND STATISTICAL ANALYSIS FOR GLP-1 AS AN ADJUNCT TO BUPRENORPHINE. MAY 21, 2025 - FEBRUARY 29, 2028. N01DA-22-2253. TASK ORDER NO. 75N95025F00002 (TO26).

Start date: May 21, 2025

NAICS: —

PSC: —

Place: MD

CONT_AWD_75N95025F00001_7529_75N95022D00017_7529

$2,349,295

Awarding agency: Department of Health and Human Services

Description: DSC MANAGEMENT AND SUPPORT. MARCH 1, 2025 TO FEBRUARY 28, 2026. N01DA-22-2253. TASK ORDER NO. 75N95025F00001 (TO25).

Start date: Mar 1, 2025

NAICS: —

PSC: —

Place: MD

CONT_AWD_75N95024F00003_7529_75N95024D00037_7529

$3,944,274

Awarding agency: Department of Health and Human Services

Description: CTN'S CLINICAL COORDINATING CENTER CONTRACT. CTN STUDY, OPTIMIZING RETENTION, DURATION AND DISCONTINUATION STRATEGIES FOR OPIOID USE DISORDER PHARMACOTHERAPY (CTN-0100). POP: 8/15/24 - 4/2/28

Start date: Aug 15, 2024

NAICS: —

PSC: —

Place: MD

CONT_AWD_75N95024F00007_7529_75N95022D00017_7529

$1,860,579

Awarding agency: Department of Health and Human Services

Description: OPTIMIZING RETENTION, DURATION AND DISCONTINUATION STRATEGIES FOR OPIOID USE DISORDER PHARMACOTHERAPY (CTN-0100). AUGUST 15, 2024 TO MARCH 31, 2028. N01DA-22-2253. TASK ORDER NO. 75N95024F00007 (TO23).

Start date: Aug 15, 2024

NAICS: —

PSC: —

Place: MD

CONT_AWD_75N95024F00008_7529_75N95022D00017_7529

$771,451

Awarding agency: Department of Health and Human Services

Description: RURAL EXPANSION OF MEDICATION TREATMENT FOR OPIOID USE DISORDER (CTN-0102). AUGUST 1, 2024 TO MARCH 31, 2026. N01DA-22-2253. TASK ORDER NO. 75N95024F00008 (TO24).

Start date: Aug 1, 2024

NAICS: —

PSC: —

Place: MD

CONT_AWD_75N95024F00001_7529_75N95022D00017_7529

$374,923

Awarding agency: Department of Health and Human Services

Description: PHARMACIST-INTEGRATED MODEL OF MEDICATION TREATMENT FOR OPIOID USE DISORDER. 12/01/2023 - 03/31/2025. N01DA-22-2253. TASK ORDER NO. 75N95024F00001 (TO17).

Start date: Dec 1, 2023

NAICS: —

PSC: —

Place: MD

CONT_AWD_75N95023F00005_7529_75N95022D00017_7529

$1,249,376

Awarding agency: Department of Health and Human Services

Description: STANDARD AND HIGH DOSE ED BUPRENORPHINE INDUCTION. 09/15/2023 - 05/31/2026. N01DA-22-2253. TASK ORDER 75N95023F00005 (TO9).

Start date: Sep 15, 2023

NAICS: —

PSC: —

Place: MD

CONT_AWD_75N95023F00011_7529_75N95022D00017_7529

$799,919

Awarding agency: Department of Health and Human Services

Description: CRAFT. SEPTEMBER 15, 2023 - MARCH 31, 2025. N01DA-22-2253. TASK ORDER NO. 75N95023F00011 (TO15).

Start date: Sep 15, 2023

NAICS: —

PSC: —

Place: MD

CONT_AWD_75N95023F00012_7529_75N95022D00017_7529

$754,669

Awarding agency: Department of Health and Human Services

Description: SECONDARY ANALYSIS. SEPTEMBER 15, 2023 - SEPTEMBER 14, 2026. N01DA-22-2253. TASK ORDER NO. 75N95023F00012 (TO16)

Start date: Sep 15, 2023

NAICS: —

PSC: —

Place: MD

CONT_AWD_75N98022F00001_7529_75N98022D00012_7529

$4,027,835

Awarding agency: Department of Health and Human Services

Description: EMMES CORP:1108738 [22-001337]

Start date: Mar 28, 2022

NAICS: —

PSC: —

Place: MD

CONT_AWD_75N98022C00001_7529_-NONE-_-NONE-

$30,142,554

Awarding agency: Department of Health and Human Services

Description: EO14042 DEVELOPMENT, STATISTICAL DESIGN, MONITORING AND COORDINATION OF VISION CLINICAL TRIALS AND EPIDEMIOLOGY RESEARCH

Start date: Nov 1, 2021

NAICS: —

PSC: —

Place: MD

CONT_AWD_HHSN271201700064C_7529_-NONE-_-NONE-

$6,970,620

Awarding agency: Department of Health and Human Services

Description: IGF::OT::IGF OTHER FUNCTION NINDS CENTER FOR CLINICAL RESEARCH RESOURCES

Start date: Sep 19, 2017

NAICS: —

PSC: —

Place: MD

CONT_AWD_HHSN275201700002C_7529_-NONE-_-NONE-

$66,032,644

Awarding agency: Department of Health and Human Services

Description: IGF::OT::IGF DATA COORDINATING CENTER FOR THE BEST PHARMACEUTICALS FOR CHILDREN ACT

Start date: Jul 28, 2017

NAICS: —

PSC: —

Place: MD

CONT_AWD_HHSN263201700001C_7529_-NONE-_-NONE-

$35,391,880

Awarding agency: Department of Health and Human Services

Description: IGF::OT::IGF EMMES NEIS-V

Start date: Oct 26, 2016

NAICS: —

PSC: —

Place: MD

CONT_AWD_HHSN26800003_7529_HHSN268201400002I_7529

$13,756,583

Awarding agency: Department of Health and Human Services

Description: IGF::OT::IGF THE NATIONAL MYELODYSPLASTIC SYNDROMES (MDS) NATURAL HISTORY STUDY, DATA COORDINATING CENTER (DCC), TASK ORDER 03, SEPTEMBER 1, 2016-FEBRUARY 28, 2018

Start date: Aug 30, 2016

NAICS: —

PSC: —

Place: MD

CONT_AWD_HHSN268201600020C_7529_-NONE-_-NONE-

$4,756,253

Awarding agency: Department of Health and Human Services

Description: IGF::OT::IGF PRODUCTION ASSISTANCE FOR CELLULAR THERAPIES (PACT) - COORDINATING CENTER (CC)

Start date: Jul 1, 2016

NAICS: —

PSC: —

Place: MD

CONT_AWD_HHSN27200008_7529_HHSN272201000049I_7529

$125,282

Awarding agency: Department of Health and Human Services

Description: IGF::OT::IGF

Start date: Nov 18, 2015

NAICS: —

PSC: —

Place: MD

CONT_AWD_HHSN272201500002C_7529_-NONE-_-NONE-

$100,150,458

Awarding agency: Department of Health and Human Services

Description: IGF::OT::IGF - STATISTICAL AND DATA COORDINATING CENTER FOR CLINICAL RESEARCH IN INFECTIOUS DISEASES(SDCC)

Start date: Feb 27, 2015

NAICS: —

PSC: —

Place: MD

NAICS and PSC are not reported for these awards in USAspending.

Source: USAspending.gov. Company totals are sums of all contract obligations across the company's USAspending recipient records for each fiscal year. This page is not affiliated with or endorsed by the U.S. government.

← Back to the full ranking